Brian Culley

Brian Culley

Company: Lineage Cell Therapeutics

Job title: Chief Executive Officer


A Further Spotlight on OpRegen – A RPE Transplant for Dry AMD with GA 11:00 am

Reiterative how a transplant of RPE cells can be both robust and endured by patients with dry-AMD Understand further the benefits of OpRegen RPE cells in specific patients with dry-AMD, as well as primary indication of RPE-photoreceptor complex regeneration (GA reduction) Evaluate how RPE cell suspensions can be reasonably scaled to marketable quantitiesRead more

day: Track 2 Day 2 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.